Growth of the Europe Personalized Medicine Biomarkers Market

The Europe personalized medicine biomarkers market is projected to witness a healthy CAGR of 15.3% during the forecast period from 2024 to 2031. It is anticipated to increase from US$ 5.2 Bn recorded in 2024 to a staggering US$ 14.1 Bn by 2031.